Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q1 EPS of ($0.29), $0.18 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.